Multiple myeloma: VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patients.

Source:http://linkedlifedata.com/resource/pubmed/id/1999714

Download in:

View as

General Info

PMID
1999714